Replies to post #101650 on Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

Phase 1 constructs get funding. Plus, PSA is almost ready for Phase 3. And Aim2Cerv is a remote possibility for funding, depending on the data.

Not according to the last raise and not according to the market cap or any other barometer we have. Again, the market does not see them getting reasonable funding. It’s almost been a year since Amgen sent the termination letter regarding NEO.... that’s still being funded by the company while they add HOT and continue to submit IND’s for more constructs.

Aim2cerv should have already been partnered and was always the plan but they failed miraculously in that endeavor as well.